A New Antibiotic Might Make for the Most Interesting Pricing Story of the Year
Shares:
On Thursday, I said that Cost Curve would be off until Monday “unless someone misbehaves.” I don’t know why I put that evil on myself. Because, sure enough, someone misbehaved.
A quick note: The number of folks who opened Cost Curve yesterday fell precipitously. I’m not worried about the statistics, but I do suspect that the experimentation with the easier-to-read
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv